Monthly Archives: February 2018

15 February 2018

OxSyBio – Parkwalk closes Investment

By |February 15th, 2018|

We are delighted to announce that Parkwalk has participated in the funding of OxSyBio, which is seeking to commercialise IP generated by Professor Hagan Bayley at the University of Oxford.

The company has the unique ability to 3D print materials that have function derived from biology, but which are not living. The company is also able to print […]

Parkwalk wins at EISA Awards

By |February 7th, 2018|

Parkwalk are delighted to have won the ‘Best EIS Fund Manager’ category at the EISA awards on the 6th February 2018 at the House of Lords.

The award recognised an extremely strong 2017 for Parkwalk, where we committed in excess of £75m to hard-science, knowledge-intensive growth companies commercialising the best of British innovation spun-out of […]

Cytora – Parkwalk closes follow-on Investment

By |February 6th, 2018|

The University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund  have closed an investment into Cytora, an artificial intelligence risk analytics spin-out from the University of Cambridge.

Cytora  raised $5.9 million in new financing from investors including divisions of QBE’s venture capital arm and Starr Cos.

QBE Ventures, Starr Global Holding, Cambridge Innovation Capital, Cambridge […]

Bodle Technologies – Parkwalk closes follow-on investment

By |February 5th, 2018|

We are delighted to announce that the Parkwalk Opportunities fund has led an investment in a £6m Series A funding round in to Bodle Technologies Limited, with participation from new investor Woodford Patient Capital Trust, as well as returning backers Oxford Sciences Innovation and the Oxford Technology and Innovations Fund.

The company intends to use the funds to […]

Brainomix – Parkwalk closes follow-on investment

By |February 5th, 2018|

We have recently closed an investment in Brainomix for the Parkwalk Opportunities EIS Fund.

Brainomix is aiming to improve stroke treatment dramatically by developing software that gives all hospitals and clinics access to reliable diagnoses for their patients.

Brainomix’s ground-breaking technology, e-ASPECTS is a clinical decision support tool that automatically implements the Alberta Stroke Program Early CT Score […]

YASA – opens new 100,000 unit Oxford production facility

By |February 1st, 2018|

YASA’s  new Oxford production facility was officially opened today by the Secretary of State for Business, Energy and Industrial Strategy, the Rt Hon Greg Clark MP.  The opening follows the signing of long-term development and supply agreements with customers in the automotive sector and a further investment of £15 million in growth funding for […]